Michael Bishop, MD, obtained his medical degree from the University of Illinois College of Medicine before completing an internship and residency at Northwestern Medicine, Chicago, IL. Following this, he completed a fellowship at Loyola University Medical Center. Prof. Bishop currently works as a Professor of Medicine and Director of the Hematopoietic Stem Cell Transplantation Program at the University of Chicago Medical Center.
Prof. Bishop is an active contributor to hematological literature, he has authored over 150 peer-reviewed articles as well as more than 30 book chapters and two books on cancer treatment and research.
Speaking on stem cell therapies in multiple myeloma
Prof. Bishop’s primary area of research is hematopoietic stem cell transplantation, with a focus on the prevention and treatment of relapse after stem call transplantation. He also works on ways to enhance the immune effects of transplanted cells against cancer.
Prof. Bishop has served as the primary investigator on clinical trials aiming to prevent and treat disease recurrence after transplantation. He also specializes in the diagnosis and treatment of patients with lymphomas and other hematologic malignancies.